Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease?
| Autor: | Albayrak, Fatih, Gür, Mustafa, Karataş, Ahmet, Koca, Süleyman Serdar, Kısacık, Bünyamin |
|---|---|
| Zdroj: | In Reumatología clínica (English Edition) March 2024 20(3):123-127 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect